Cargando…
Activation of Retinoid X Receptor increases dopamine cell survival in models for Parkinson's disease
BACKGROUND: Parkinson's disease (PD) is caused by degeneration of dopamine (DA) neurons in the ventral midbrain (vMB) and results in severely disturbed regulation of movement. The disease inflicts considerable suffering for the affected and their families. Today, the opportunities for pharmacol...
Autores principales: | Friling, Stina, Bergsland, Maria, Kjellander, Susanna |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800113/ https://www.ncbi.nlm.nih.gov/pubmed/20003337 http://dx.doi.org/10.1186/1471-2202-10-146 |
Ejemplares similares
-
Of Retinoids and Organotins: The Evolution of the Retinoid X Receptor in Metazoa
por: Fonseca, Elza, et al.
Publicado: (2020) -
Retinoid X Receptor Antagonists
por: Watanabe, Masaki, et al.
Publicado: (2018) -
Retinoid X Receptor Activation Prevents Diabetic Retinopathy in Murine Models
por: Dorofeeva, Iuliia, et al.
Publicado: (2023) -
Retinoid X Receptor activation prevents diabetic retinopathy in murine models
por: Dorofeeva, Iuliia, et al.
Publicado: (2023) -
Retinoic Acid and Retinoid X Receptors
por: Schubert, Michael, et al.
Publicado: (2023)